Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Aynur Küçükçongar Yavaş, Ayşenur Engin Erdal, Berrak Bilginer Gürbüz, Aysel Ünlüsoy Aksu & Çiğdem Seher Kasapkara. (2023) Assessment of the diagnosis, treatment, and follow-up of a group of Turkish pediatric glycogen storage disease type 1b patients with varying clinical presentations and a novel mutation. Journal of Pediatric Endocrinology and Metabolism 36:11, pages 1092-1099.
Crossref
Crossref
Andrej N. Surkov, Aleksandr A. Baranov, Lejla S. Namazova-Baranova, Anna L. Arakelyan, Evgenij E. Bessonov & Natal’ya V. Zhurkova. (2023) Glycogen storage disease type Ib: modern understanding of the pathogenesis of neutropenia and prospects for its treatment with empagliflozin. Pediatric pharmacology 20:5, pages 498-506.
Crossref
Crossref
Lauren V. Collen, Peter E. NewburgerScott B. Snapper. (2023) Clinical Remission of Severe Crohn’s Disease with Empagliflozin Monotherapy in a Pediatric Patient with Glycogen Storage Disease Type 1b. JPGN Reports 4:4, pages e356.
Crossref
Crossref
Jiamin Zhong, Yannian Gou, Piao Zhao, Xiangyu Dong, Meichun Guo, Aohua Li, Ailing Hao, Hue H. Luu, Tong‐Chuan He, Russell R. Reid & Jiaming Fan. (2023) Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies. Pediatric Discovery.
Crossref
Crossref
Ersin Gümüş & Hasan Özen. (2023) Glycogen storage diseases: An update. World Journal of Gastroenterology 29:25, pages 3932-3963.
Crossref
Crossref
Aristidis Tsatsakis, Tatiana Oikonomopoulou, Taxiarchis Nikolouzakis, Elena Vakonaki, Manolis Tzatzarakis, Matthaios Flamourakis, Elisavet Renieri, Persefoni Fragkiadaki, Evaggelia Iliaki, Maria Bachlitzanaki, Vasiliki Karzi, Ioanna Katsikantami, Fotios Kakridonis, Eleftheria Hatzidaki, Maria Tolia, Andrey Svistunov, Demetrios Spandidos, Dragana Nikitovic, John Tsiaoussis & Aikaterini Berdiaki. (2023) Role of telomere length in human carcinogenesis (Review). International Journal of Oncology 63:1.
Crossref
Crossref
Sarah C. Grünert, Annieke Venema, Jamas LaFreniere, Blair Schneider, Enrique Contreras, Saskia B. Wortmann & Terry G. J. Derks. (2023) Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study. JIMD Reports 64:3, pages 252-258.
Crossref
Crossref
Arianna Maiorana, Francesco Tagliaferri & Carlo Dionisi-Vici. (2023) Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders. Frontiers in Endocrinology 14.
Crossref
Crossref
Abrar Turki, Sylvia Stockler, Sandra Sirrs, Kathleen Duddy, Gloria Ho & Rajavel Elango. (2023) Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using 13C-glucose breath test. Molecular Genetics and Metabolism Reports 34, pages 100955.
Crossref
Crossref
Karina Colonetti, Filippo Pinto e Vairo, Marina Siebert, Tatiéle Nalin, Soraia Poloni, Luiz Fernando Wurdig Roesch, Carolina Fischinger Moura de Souza, Franciele Cabral Pinheiro & Ida Vanessa Doederlein Schwartz. (2023) Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects?. Cytokine 162, pages 156088.
Crossref
Crossref
Zsigmond Lédeczi, Rebeka Pittner, Gergely Kriván, Tamás Kardon & Balázs Legeza. (2023) Empagliflozin restores neutropenia and neutrophil dysfunction in a young patient with severe congenital neutropenia type 4. The Journal of Allergy and Clinical Immunology: In Practice 11:1, pages 344-346.e1.
Crossref
Crossref
Rebecca K. Halligan, R. Neil Dalton, Charles Turner, Katherine A. Lewis & Helen R. Mundy. (2022) Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Konstantinos Makrilakis, Aikaterini Barmpagianni & Maria Veiga-da-Cunha. (2022) Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report. Cureus.
Crossref
Crossref
Eran Tallis, Cecile L. Karsenty, Amanda B. Grimes, Lina B. Karam, Sarah H. Elsea, Vernon Reed Sutton, Brandy L. Rawls‐Castillo, Ning Liu & Claudia Soler‐Alfonso. (2022)
Untargeted metabolomic profiling in a patient with glycogen storage disease
Ib
receiving empagliflozin treatment
. JIMD Reports 63:4, pages 309-315.
Crossref
Crossref
Sang Wan Sim, Yuyeon Jang, Tae Sub Park, Byung-Chul Park, Young Mok Lee & Hyun Sik Jun. (2022) Molecular mechanisms of aberrant neutrophil differentiation in glycogen storage disease type Ib. Cellular and Molecular Life Sciences 79:5.
Crossref
Crossref
John H. Walter, Philippe Labrune & Pascal Laforêt. 2022. Inborn Metabolic Diseases. Inborn Metabolic Diseases
179
200
.
Reid Thompson, John Jefferies, Suya Wang, William T. Pu, Clifford Takemoto, Brittany Hornby, Andrea Heyman, Michael T. Chin & Hilary J. Vernon. (2021) Current and future treatment approaches for Barth syndrome. Journal of Inherited Metabolic Disease 45:1, pages 17-28.
Crossref
Crossref
James A. Connelly & Kelly Walkovich. (2021) Diagnosis and therapeutic decision-making for the neutropenic patient. Hematology 2021:1, pages 492-503.
Crossref
Crossref
Alessandro Rossi, Erasmo Miele, Simona Fecarotta, Maria Veiga-da-Cunha, Massimo Martinelli, Carmine Mollica, Maria D’Armiento, Enza Mozzillo, Pietro Strisciuglio, Terry G. J. Derks, Annamaria Staiano & Giancarlo Parenti. (2021) Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report. Italian Journal of Pediatrics 47:1.
Crossref
Crossref
Marina Mayumi Vendrame TAKAO, Natascha Silva SANDY, Adriana Gut Lopes RICCETTO & Adriana Maria Alves DE TOMMASO. (2021) LONG TERM MANAGEMENT OF GLYCOGEN STORAGE DISEASE TYPE 1B: A BRAZILIAN TERTIARY CENTER EXPERIENCE. Arquivos de Gastroenterologia 58:1, pages 87-92.
Crossref
Crossref
Sarah C. Grünert, Roland Elling, Bärbel Maag, Saskia B. Wortmann, Terry G. J. Derks, Luciana Hannibal, Anke Schumann, Stefanie Rosenbaum-Fabian & Ute Spiekerkoetter. (2020) Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Jiequan Wang, Yaru Liu, Qingrong Xia, Quan Xia, Baoshi Wang, Chenchen Yang, Jun Liang & Xinhua Liu. (2020) Potential roles of telomeres and telomerase in neurodegenerative diseases. International Journal of Biological Macromolecules 163, pages 1060-1078.
Crossref
Crossref
David A. Weinstein. (2020) When sugar isn’t sweet: neutropenia in GSD-Ib. Blood 136:9, pages 1015-1016.
Crossref
Crossref
Saskia B. Wortmann, Johan L. K. Van HoveTerry G. J. Derks, Nathalie ChevalierVijaya KnightAndreas Koller, Esmee OussorenJohannes A. Mayr, Francjan J. van Spronsen, Florian B. Lagler, Sommer GaughanEmile Van Schaftingen & Maria Veiga-da-Cunha. (2020) Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood 136:9, pages 1033-1043.
Crossref
Crossref
Adrijan Sarajlija, Maja Djordjevic, Bozica Kecman, Anita Skakic, Sonja Pavlovic, Srdjan Pasic & Maja Stojiljkovic. (2020) Impact of genotype on neutropenia in a large cohort of Serbian patients with glycogen storage disease type Ib. European Journal of Medical Genetics 63:3, pages 103767.
Crossref
Crossref
Sang Wan Sim, David A. Weinstein, Young Mok Lee & Hyun Sik Jun. (2019) Glycogen storage disease type Ib: role of glucose‐6‐phosphate transporter in cell metabolism and function. FEBS Letters 594:1, pages 3-18.
Crossref
Crossref
Dina Khalaf, Heather Bell, David Dale, Vikas Gupta, Hanna Faghfoury, Chantal F. Morel, Anne Tierens, David A. Weinstein, Jiong Yan, Santhosh Thyagu & Dawn Maze. (2019) A case of secondary acute myeloid leukemia on a background of glycogen storage disease with chronic neutropenia treated with granulocyte colony stimulating factor. JIMD Reports 49:1, pages 37-42.
Crossref
Crossref
Sabine Iberl, Anne-Louise Meyer, Gunnar Müller, Sebastian Peters, Siw Johannesen, Ines Kobor, Fabian Beier, Tim H. Brümmendorf, Christina Hart, Roland Schelker, Wolfgang Herr, Ulrich Bogdahn & Jochen Grassinger. (2019) Effects of continuous high-dose G-CSF administration on hematopoietic stem cell mobilization and telomere length in patients with amyotrophic lateral sclerosis – a pilot study. Cytokine 120, pages 192-201.
Crossref
Crossref
Maria Veiga-da-Cunha, Nathalie ChevalierXavier StephenneJean-Philippe DefourNicole PacziaAlina Ferster, Younes AchouriJoseph P. DewulfCarole L. LinsterGuido T. BommerEmile Van Schaftingen. (2019) Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proceedings of the National Academy of Sciences 116:4, pages 1241-1250.
Crossref
Crossref
David C. Dale, Audrey Anna Bolyard, Tracy Marrero, Merideth L. Kelley, Vahagn Makaryan, Emily Tran, Jamie Leung, Laurence A. Boxer, Priya S. Kishnani, Stephanie Austin, Corbinian Wanner, Iris A. Ferrecchia, Dina Khalaf, Dawn Maze, Joanne Kurtzberg, Cornelia Zeidler, Karl Welte & David A. Weinstein. (2019) Neutropenia in glycogen storage disease Ib. Current Opinion in Hematology 26:1, pages 16-21.
Crossref
Crossref
Abrar Turki, Sylvia Stockler, Sandra Sirrs, Kathleen Duddy, Gloria Ho & Rajavel Elango. (2022) Impact of Hematopoietic Stem Cell Transplantation in Glycogen Storage Disease Type Ib: A Single-Subject Research Design Using 13C-Glucose Breath Test. SSRN Electronic Journal.
Crossref
Crossref